Tag: NeoCast
Arsenal Medical completes enrolment of initial EMBO-02 study cohort
Arsenal Medical has announced the complete enrolment of an initial cohort of 10 patients in the EMBO-02 clinical study evaluating NeoCast for the treatment...
Arsenal Medical launches EMBO-02 study to assess NeoCast in cSDH treatment
Arsenal Medical today announced the initiation of the EMBO-02 clinical study of NeoCast in the treatment of chronic subdural haematomas (cSDHs). NeoCast is a...
Novel liquid embolic agent meets primary feasibility and safety endpoints in...
Arsenal Medical has announced that NeoCast—a first-of-its-kind, shear-responsive liquid embolic material designed for deep distal penetration—met its primary feasibility and safety endpoints in the...
Arsenal Medical announces treatment of first patient with NeoCast embolic biomaterial
Arsenal Medical has today announced enrolment of the first patient treated with the company’s investigational NeoCast embolic biomaterial for neurovascular conditions.
The patient was successfully...
